Back

Risk stratification for systemic lupus erythematosus associated pulmonary hypertension by simplified ESC/ERS guidelines: data from SOPHIE registry

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Infection and immunity in heart disease Autoimmune/Chronic Inflammatory Disorders and Heart Disease ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Mi ZHOU

Sichuan provincial people's hospital affiliate Wenjiang hospital, Chengdu (China)

5 More presentations in this session

Presentation thumbnail
COVID-19 vaccination in the pediatric age and risk for myocarditis
Doctor A. Aimo (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
Cd4+ t cell phenotypes, autoantibodies and transcriptional signatures overlap between myocarditis, ischemic and nonischemic heart failure, suggesting shared inflammatory pathogenic mechanisms
Mr C. Sandel (Oklahoma City, US)
Abstract Slides Video
Presentation thumbnail
The effects of human papillomavirus vaccination on cardiovascular diseases. The United States National Health and Nutrition Examination Survey
Mr O. Chou (Hong Kong, HK)
Abstract Slides Video
Presentation thumbnail
Differences in coronary flow reserve and flow-mediated dilation between plaque psoriasis and psoriatic arthritis
Doctor I. Ikonomidis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Coronary artery calcium score in people living with HIV. Results from the French CAC study.
Professor F. Boccara (Paris, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Infection and immunity in heart disease

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Predictive value of echocardiographic parameters for screening pulmonary hypertension in the revised ESC/ERS guidelines
thumbnail
Congress Presentation
Value of myocardial strain techniques for early diagnosis of pulmonary arterial hypertension in scleroderma patients
thumbnail
Congress Presentation
Left atrial strain demonstrates the ability to distinguish patients with pre and post-capillary pulmonary hypertension

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources